HuagongsheHuagongshe Chemistry Print Report · For research reference only
(+-)-1,4-Diazabicyclo[4.4.0]decane → HCID 59605237, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (+-)-1,4-Diazabicyclo[4.4.0]decane | HCID 2876391 | — |
| Reactant | 4-(8-(bromomethyl)-9-methyl-2-(2-methyl-1H-benzo[d]imidazol-1-yl)-9H-purin-6-yl)morpholine | HCID 59605812 | — |
| Product | HCID 59605237 | HCID 59605237 | — |
Reaction Steps
4-(8-(Bromomethyl)-9-methyl-2-(2-methyl-1H-benzo[d]imidazol-1-yl)-9H-purin-6-yl)morpholine (50 mg) was reacted with octahydro-1H-pyrido[1,2-a]pyrazine via General Procedure E to give 24 mg of 284 following reverse phase purification. MS (Q1) 502.3 (M)+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08394796B2 |
| Source dataset | uspto-grants-2013_03 |
| ORD ID | ord-93b9a6852eb04998ae08a72f5fec647f |
| Source note | uspto-grants-2013_03 |